New study aims to improve breast cancer outcomes for patients over 70

NCT ID NCT03818087

Ongoing Knowledge-focused Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 253 breast cancer patients aged 70 and older over five years. Researchers collect data on treatments, side effects, and quality of life to understand what helps older adults stick with their care. The goal is to find ways to improve outcomes and tailor treatments for this age group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal ways to tailor breast cancer care for older adults, improving treatment adherence and quality of life.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all older patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Brigham and Women Hospital

Boston, Massachusetts, 02215, United States
Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Lifespan Cancer Institute

Providence, Rhode Island, 02903, United States
Northern Light Cancer Care

Bangor, Maine, 04401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.